Close Menu

What's It Worth?

Open Access News links to two articles that take different sides on the question of whether the open access movement is anti-publishing. At Scholarly Kitchen, Kent Anderson says it is. "The value proposition is that content is so worthless that you have to pay to have it published, and you can't charge for it even then," he writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.